Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials Public Deposited

Downloadable Content

Download PDF
Creator
  • Dooley, Mary A
    • Affiliation: School of Medicine, Department of Medicine, Division of Nephrology and Hypertension
  • Pendergraft, William F
    • Affiliation: School of Medicine, Department of Medicine, Division of Nephrology and Hypertension
  • Corapi, Kristin M
    • Other Affiliation: Division of Nephrology, Department of Medicine, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114, USA
Abstract
  • Abstract Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with diverse manifestations. Although the approval of new therapies includes only one agent in 50 years, a number of promising new drugs are in development. Lupus nephritis is a dreaded complication of SLE as it is associated with significant morbidity and mortality. Advancing the treatment of lupus nephritis requires well-designed clinical trials and this can be challenging in SLE. The major obstacles involve identifying the correct population of patients to enroll and ensuring that a clinically appropriate and patient-centered endpoint is being measured. In this review, we will first discuss the clinical utility of endpoints chosen to represent lupus nephritis in global disease activity scales. Second, we will review completed and active trials focused on lupus nephritis and discuss the endpoints chosen. There are many important lessons to be learned from existing assessment tools and clinical trials. Reviewing these points will help ensure that future efforts will yield meaningful disease activity measures and well-designed clinical trials to advance our understanding of lupus management.
Date of publication
Identifier
  • doi:10.1186/s13075-015-0621-6
Resource type
  • Article
Rights statement
  • In Copyright
Rights holder
  • Corapi et al.; licensee BioMed Central.
Language
  • English
Bibliographic citation
  • Arthritis Research & Therapy. 2015 Apr 28;17(1):110
Publisher
  • BioMed Central
Parents:

This work has no parents.

Items